Is it possible to protect pediatric research subjects without blocking appropriate research?
作者信息
Wendler David
机构信息
Department of Bioethics, National Institutes of Health, Bethesda, MD 20892, USA.
出版信息
J Pediatr. 2008 Apr;152(4):467-70. doi: 10.1016/j.jpeds.2007.09.027.
Abstract
摘要
相似文献
1
Is it possible to protect pediatric research subjects without blocking appropriate research?是否有可能在不阻碍适当研究的情况下保护儿科研究受试者？
J Pediatr. 2008 Apr;152(4):467-70. doi: 10.1016/j.jpeds.2007.09.027.
2
The ethics and regulation of research with human subjects, Carl Coleman, Jerry Menikoff, Jesse Goldner, and Nancy Dubler, eds., (LexisNexis) 2005.《人体研究的伦理与监管》，卡尔·科尔曼、杰里·梅尼科夫、杰西·戈德纳和南希·杜布勒主编，（律商联讯）2005年。
J Law Med Ethics. 2006 Summer;34(2):465-6. doi: 10.1111/j.1748-720X.2006.00053.x.
3
Common Rule Revised: Opportunities Lost.《通用规则》修订：错失的机遇。
Am J Bioeth. 2017 Jul;17(7):46-48. doi: 10.1080/15265161.2017.1328538.
4
The Common Rule, Updated.《通用规则》更新版
N Engl J Med. 2017 Feb 16;376(7):613-615. doi: 10.1056/NEJMp1700736. Epub 2017 Jan 19.
5
Revised 'Common Rule' Shapes Protections For Research Participants.修订后的“通用规则”为研究参与者提供了保护。
Health Aff (Millwood). 2017 May 1;36(5):784-788. doi: 10.1377/hlthaff.2017.0307.
6
The French law on "protection of persons undergoing biomedical research": implications for the U.S.法国“保护参与生物医学研究人员”法律：对美国的影响
J Law Med Ethics. 2003 Fall;31(3):434-41. doi: 10.1111/j.1748-720x.2003.tb00106.x.
7
Introduction: Vulnerability in biomedical research.引言：生物医学研究中的脆弱性。
J Law Med Ethics. 2009 Spring;37(1):6-11. doi: 10.1111/j.1748-720X.2009.00345.x.
8
[Pediatric research is necessary. The children must be guaranteed with a complete protection].儿科研究是必要的。必须确保儿童得到全面保护。
Lakartidningen. 2004 Jun 24;101(26-27):2238-9.
9
Research-related injury compensation policies of U.S. research institutions.美国研究机构的科研相关伤害补偿政策。
IRB. 2014 Jan-Feb;36(1):12-9.
10
Children as research subjects: moral disputes, regulatory guidance, and recent court decisions.儿童作为研究对象：道德争议、监管指南及近期法院判决
Mt Sinai J Med. 2006 May;73(3):596-604.
引用本文的文献
1
Mindfulness-Based Intervention Development for Children and Adolescents.针对儿童和青少年的基于正念的干预措施开发
Mindfulness (N Y). 2020 Aug;11(8):1868-1883. doi: 10.1007/s12671-020-01360-3. Epub 2020 May 19.
2
The feasibility and acceptability of research magnetic resonance imaging in adolescents with moderate-severe neuropathic pain.针对中重度神经性疼痛青少年进行研究性磁共振成像的可行性与可接受性。
Pain Rep. 2020 Jan 21;5(1):e807. doi: 10.1097/PR9.0000000000000807. eCollection 2020 Jan-Feb.
3
Defining the Boundaries of a Right to Adequate Protection: A New Lens on Pediatric Research Ethics.界定充分保护权的界限：儿科研究伦理的新视角
J Med Philos. 2017 Apr 1;42(2):132-153. doi: 10.1093/jmp/jhw038.
4
Defining pathways for development of disease-modifying therapies in children with type 1 diabetes: a consensus report.确定1型糖尿病儿童疾病改善疗法的发展路径：一份共识报告。
Diabetes Care. 2015 Oct;38(10):1975-85. doi: 10.2337/dc15-1429.
5
Ethical aspects of clinical research with minors.未成年人临床研究的伦理问题。
Eur J Pediatr. 2013 Jul;172(7):859-66. doi: 10.1007/s00431-012-1856-8. Epub 2012 Oct 17.
6
Ethics of clinical research with mentally ill persons.精神病人参与临床研究的伦理问题。
Eur Arch Psychiatry Clin Neurosci. 2012 Aug;262(5):441-52. doi: 10.1007/s00406-011-0287-2. Epub 2012 Jan 3.
7
Ethical issues in naturalistic versus controlled trials.自然主义试验与对照试验中的伦理问题。
Dialogues Clin Neurosci. 2011;13(2):173-82. doi: 10.31887/DCNS.2011.13.2/hhelmchen.
8
Frontline ethical issues in pediatric clinical research: ethical and regulatory aspects of seven current bottlenecks in pediatric clinical research.儿科临床研究中的前沿伦理问题：儿科临床研究中七个当前瓶颈的伦理和监管方面。
Eur J Pediatr. 2010 Dec;169(12):1541-8. doi: 10.1007/s00431-010-1268-6. Epub 2010 Jul 29.
9
Challenges of functional imaging research of pain in children.儿童疼痛功能成像研究的挑战。
Mol Pain. 2009 Jun 16;5:30. doi: 10.1186/1744-8069-5-30.
10
Ethical principles and legal requirements for pediatric research in the EU: an analysis of the European normative and legal framework surrounding pediatric clinical trials.欧盟儿科研究的伦理原则和法律要求：对围绕儿科临床试验的欧洲规范和法律框架的分析
Eur J Pediatr. 2009 Oct;168(10):1225-34. doi: 10.1007/s00431-008-0915-7. Epub 2009 Jan 14.
本文引用的文献
1
A standard for assessing the risks of pediatric research: pro and con.评估儿科研究风险的一项标准：赞成与反对
J Pediatr. 2007 Jun;150(6):579-82. doi: 10.1016/j.jpeds.2007.02.018.
2
Compressing drug development timelines in oncology using phase '0' trials.利用“0期”试验缩短肿瘤学药物研发周期。
Nat Rev Cancer. 2007 Feb;7(2):131-9. doi: 10.1038/nrc2066.
3
Pediatric research and the federal minimal risk standard.儿科研究与联邦最低风险标准。
JAMA. 2006 Feb 15;295(7):759; author reply 759-60. doi: 10.1001/jama.295.7.759-a.
4
Eliminating the daily life risks standard from the definition of minimal risk.从最低风险的定义中剔除日常生活风险标准。
J Med Ethics. 2005 Jan;31(1):35-8. doi: 10.1136/jme.2004.010470.
5
Minimal risk as an international ethical standard in research.作为研究中的一项国际伦理标准的最小风险。
J Med Philos. 2004 Jun;29(3):351-78. doi: 10.1080/03605310490500545.
6
Clinical trials in children.儿童临床试验。
Lancet. 2004;364(9436):803-11. doi: 10.1016/S0140-6736(04)16942-0.
7
The French law on "protection of persons undergoing biomedical research": implications for the U.S.法国“保护参与生物医学研究人员”法律：对美国的影响
J Law Med Ethics. 2003 Fall;31(3):434-41. doi: 10.1111/j.1748-720x.2003.tb00106.x.
8
Pediatric drug labeling: improving the safety and efficacy of pediatric therapies.儿科药物标签：提高儿科治疗的安全性和有效性。
JAMA. 2003 Aug 20;290(7):905-11. doi: 10.1001/jama.290.7.905.
9
1931 German guidelines on human experimentation.1931年德国人体实验指南。
Int Dig Health Legis. 1980;31(2):408-11.
10
The Nuremberg Code.《纽伦堡法典》
JAMA. 1996 Nov 27;276(20):1691.
Zotero 插件